Immune Dysregulation in a Child With SOD1-Related Neurological Disease.

Am J Med Genet A

Department of Medical Genetics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

Published: December 2024

AI Article Synopsis

  • Spastic tetraplegia and axial hypotonia (STAHP) is a rare neurological disorder in children linked to biallelic SOD1 deficiency, marked by progressive symptoms starting before age 2.
  • Five studies have reported nine cases, primarily related to a common genetic variant in SOD1 that disrupts enzyme function, with one case involving a novel SOD1 variant in a 19-year-old male.
  • The patient exhibited significant neurological decline and MRI findings of cerebellar atrophy, plus new symptoms including immune dysregulation and physical anomalies not previously associated with STAHP.

Article Abstract

Spastic tetraplegia and axial hypotonia (STAHP) associated with biallelic SOD1 deficiency is a recently described neurological disorder affecting children. Five studies have described a total of nine cases thus far, all characterized by the onset of progressive spastic tetraplegia beginning before 2 years of age. All but two of these cases are associated with homozygosity for the same genetic variant (NM_000454.4:c.335dupG; NP_000445.1:p.Cys112Trpfs*11) that leads to a non-functional enzyme product. More recently, a homozygous 3-base pair in-frame deletion (NM_000454.5: c.357_357+2delGGT) and a truncating frameshift variant (NM_000454.5: c.52_56del5ins154) in SOD1 have been described in similarly affected patients lacking SOD1 activity. Here we expand on the neurological and extra-neuronal phenotypes of STAHP in a patient with a novel homozygous SOD1 variant predicted to result in disrupted calcium- and zinc-binding activity of the encoded enzyme. We describe a 19-year-old male born to consanguineous parents who is homozygous for an NM_000454.4:c.369_371del SOD1 variant. The patient had progressive neuromuscular degeneration with onset before 1 year of age, consistent with a diagnosis of STAHP. Brain MRI at 7 years of age showed cerebellar atrophy, as has previously been described in this condition, as well as small optic nerves and a hypoplastic optic chiasm, which have not been reported previously. Our patient also exhibited clinical features of immune dysregulation with treatment-refractory inflammatory bowel disease, asthma, recurrent infections, and dermatitis. Overall, the early-onset progressive neurological disorder in our patient, found in association with homozygosity for an SOD1 variant that is predicted to result in impaired function of the transcribed protein, is consistent with a diagnosis of STAHP. Our patient also demonstrates optic atrophy and disrupted immune homeostasis, which have not been previously described as part of this condition. Taken together with previous case studies in children carrying loss-of-function variants of SOD1, this case highlights a possible role for antioxidant therapy in slowing disease progression in patients lacking SOD1 activity. These cases also draw attention to the need for careful consideration of possible harmful neuronal and extra-neuronal complications of proposed SOD1 knockdown therapies against ALS.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.63949DOI Listing

Publication Analysis

Top Keywords

sod1 variant
12
sod1
9
immune dysregulation
8
spastic tetraplegia
8
neurological disorder
8
patients lacking
8
lacking sod1
8
sod1 activity
8
stahp patient
8
variant predicted
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!